LUT014 gel significantly reduces acne-like rashes from anti-EGFR therapies in colorectal cancer patients, improving quality of life. The phase 2 trial showed 70% improvement with high-dose gel, ...
A research team from the UCLA Health Jonsson Comprehensive Cancer Center, the University of Texas MD Anderson Cancer Center, and collaborators have demonstrated that a novel topical BRAF inhibitor gel ...
Itchy skin (pruritus) without a rash may be caused by dry skin, allergies, bug bites, or an underlying medical condition. Health issues like liver disease, kidney disease, and thyroid disorders can ...
Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical BRAF inhibitor gel called LUT014 ...
Please provide your email address to receive an email when new articles are posted on . ATR-04 is currently being developed to treat dermal toxicity from epidermal growth factor receptor inhibitor ...
No longer confined to cancer centers, skin complications of cancer therapies are now commonly encountered at the community level and require the care of a dermatologist.